3 Takeaways As FDA Dishes On Interchangeable Biosimilars
The U.S. Food and Drug Administration's long-awaited guidance on biosimilar interchangeability contains lots of flexible language that means the coveted designation could be more attainable for some products than others, experts...To view the full article, register now.
Already a subscriber? Click here to view full article